The biological rationale behind our evidence of systemic autophagy impairment in RTT patients carrying the MeCP2 mutation is difficult to interpret because the MeCP2 nuclear role remains unclear and few genes whose expression is altered in MeCP2 mutated tissues have been reported. This evidence concerns the gene MECP2 and Rett syndrome.